MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/idr.s422363

Медицинская библиотека · Infection and drug resistance · 2023

Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification.

Luo Dan, Yang Bo-Yi, Qin Kai, Shi Chong-Yu, Wei Nian-Sa, Li Hai, Qin Yi-Xiang, Liu Gang, Qin Xiao-Ling, Chen Shi-Yi, Guo Xiao-Jing, Gan Li, Xu Ruo-Lan, Dong Bai-Qing, Li Jing

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Distinguishing latent tuberculosis infection (LTBI) from active tuberculosis (ATB) is important to control the prevalence of tuberculosis; however, there is currently no effective method. The aim of this study was to discover specific metabolites through fecal untargeted metabolomics to discriminate ATB, individuals with LTBI, and healthy controls (HC) and to probe the metabolic perturbation associated with the progression of tuberculosis.

PATIENTS AND

METHODS

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed to comprehensively detect compounds in fecal samples from HC, LTBI, and ATB patients. Differential metabolites between the two groups were screened, and their underlying biological functions were explored. Candidate metabolites were selected and enrolled in LASSO regression analysis to construct diagnostic signatures for discriminating between HC, LTBI, and ATB. A receiver operating characteristic (ROC) curve was applied to evaluate diagnostic value. A nomogram was constructed to predict the risk of progression of LTBI.

RESULTS

A total of 35 metabolites were found to exist differentially in HC, LTBI, and ATB, and eight biomarkers were selected. Three diagnostic signatures based on the eight biomarkers were constructed to distinguish between HC, LTBI, and ATB, demonstrating excellent discrimination performance in ROC analysis. A nomogram was successfully constructed to evaluate the risk of progression of LTBI to ATB. Moreover, 3,4-dimethylbenzoic acid has been shown to distinguish ATB patients with different responses to etiological tests.

CONCLUSION

This study constructed diagnostic signatures based on fecal metabolic biomarkers that effectively discriminated HC, LTBI, and ATB, and established a predictive model to evaluate the risk of progression of LTBI to ATB. The results provide scientific evidence for establishing an accurate, sensitive, and noninvasive differential diagnosis scheme for tuberculosis.

Для цитирования: Luo Dan, Yang Bo-Yi, Qin Kai, Shi Chong-Yu, Wei Nian-Sa, Li Hai, Qin Yi-Xiang, Liu Gang, Qin Xiao-Ling, Chen Shi-Yi, Guo Xiao-Jing, Gan Li, Xu Ruo-Lan, Dong Bai-Qing, Li Jing. Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification.. Infection and drug resistance. 2023. DOI: 10.2147/idr.s422363.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.